Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid

Davidson, B; Totsch, M; Wohlschlaeger, J; Hager, T; Pinamonti, M.
The diagnostic role of BAP1 in serous effusions
HUM PATHOL. 2018; 79: 122-126.
Web of Science PubMed FullText FullText_MUG

 

Authors Med Uni Graz:
Tötsch Martin
Altmetrics:

Dimensions Citations:

Plum Analytics:
Abstract:
The aim of this study was to analyze the diagnostic role of BAP1 in effusion cytology. Effusions (n = 258), consisting of 53 malignant mesotheliomas and 205 other cancers, the majority carcinomas (62 breast, 60 ovarian, 31 lung, 51 carcinomas of other origin, 1 melanoma), were analyzed for BAP1 expression using immunohistochemistry. BAP1 was lost in 46 (87%) mesotheliomas compared with 4 (2%) of 205 other cancers (P < .001), resulting in sensitivity and specificity of 87% and 98%, respectively. There was no significant difference between peritoneal (n = 14) and pleural (n = 39) mesotheliomas. The 4 carcinomas with loss of BAP1 included 1 ovarian, 1 breast, 1 uterine cervical, and 1 gastric carcinoma. The present study supports the role of BAP1 as a highly sensitive and specific marker for malignant mesothelioma in serous effusions and argues for inclusion of this test in all specimens in which this diagnosis is considered. (C) 2018 Elsevier Inc. All rights reserved.

Find related publications in this database (Keywords)
BAP1
Malignant mesothelioma
Carcinoma
Effusions
Immunohistochemistry
Diagnosis
© Meduni GrazImprint